Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Apply
Dabrafenib & Trametinib
Clinical Study To Further Evaluate The Efficacy Of Dabrafenib Plus Trametinib In Patients With Rare BRAF V600E Mutation-Positive Unresectable or Metastatic Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step